Previous 10 | Next 10 |
Medidata Solutions (NASDAQ: MDSO ): Q4 Non-GAAP EPS of $0.45 beats by $0.08 ; GAAP EPS of $0.23 beats by $0.12 . More news on: Medidata Solutions, Inc., Earnings news and commentary, Tech stocks news, Read more ...
Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter of 2018. “In 2018, we expanded our market leadership in life sciences, and proved that our unique data and AI capabilities can reinvent the way treatments are developed and commercialized,'' said...
ARCC , AYR , FIS , HUN , IPGP , JLL , MDSO , MLM , NNN , NP , NRZ , OMC , ONDK , SABR , SHOP , STE , TAP , TOWR , UAA , USFD , WEC , WELL More news on: Ares Capital, Aircastle Limited, Fidelity National Information Services, Inc. Read more ...
Medidata Solutions (NASDAQ: MDSO ) is scheduled to announce Q4 earnings results on Tuesday, February 12th, before market open. The consensus EPS Estimate is $0.37 (-9.8% Y/Y) and the consensus Revenue Estimate is $167.92M (+18.9% Y/Y). Over the last 2 years, MDSO has beaten EPS estima...
Medidata (NASDAQ: MDSO ) and Cognizant (NASDAQ: CTSH ) enter a life sciences strategic alliance with Cognizant developing a comprehensive set of managed services and solutions for Medidata's platform. More news on: Medidata Solutions, Inc., Cognizant Technology Solutions Corporation R...
Turnkey solutions will accelerate and optimize operational aspects of a clinical trial by bringing together industry-leading life science software with world-class managed services Life science organizations of all sizes and therapeutic areas can leverage enterprise-grade technology...
Introduction Medidata Solutions, Inc. ( MDSO ) provides cloud-based solutions worldwide for pharmaceutical, biotechnology and medical device companies. The company has a solid history of growth which is expected to slow through 2019. Over the last quarter the company has started to ex...
NEW YORK, Feb. 01, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Medidata Solutions, Inc. (NASDAQ:MDSO), National Instruments Corporation ...
Medidata (NASDAQ: MDSO) today announced that it will release its fourth quarter 2018 financial results before the market opens on Tuesday, February 12, 2019. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results and b...
“I think the biggest innovations of the 21st century will be the intersection of biology and technology. A new era is beginning. Steve Jobs, as quoted in Steve Jobs by Walter Isaacson In 2003 the Human Genome Project succeeded at fully sequencing and mapping the genetic code of ...
News, Short Squeeze, Breakout and More Instantly...
Medidata Solutions Inc. Company Name:
MDSO Stock Symbol:
NASDAQ Market:
Study Site Analytics, available through iMedidata.com, helps sites manage performance with a dashboard providing consistent, standardized metrics across sites Dashboard includes metrics for enrollment, screen failure, and early termination, with anonymized benchmark comparisons to o...
Company Celebrates 20 Years of Innovation Under Tarek Sherif’s Leadership; Transforming Drug Development and Clinical Trial Technology Medidata celebrates 20 years of innovation as the Operating System for Life Sciences Company dedicates success to the support an...
Life Science Executives Agree that Precision Medicine Represents a New Era in Drug Development , According to the Newsweek Vantage and Medidata Survey Report Investment in IT systems is one of the top three barriers to precision medicine Unified data strategies...